WuXi AppTec still sees sales growing and expansions rolling in 2024 despite concerns over US biosecurity bill fkansteiner Tue, 03/19/2024 - 16:12
After monumental MASH nod, Madrigal plots $600M stock sale to support Rezdiffra launch zbecker Tue, 03/19/2024 - 16:09
Takeda's Iclusig wins first-line FDA nod to treat rare Philadelphia chromosome-positive ALL kdunleavy Tue, 03/19/2024 - 14:57
Gilead CEO Daniel O'Day collects 5% pay raise to $22.6M, his largest compensation package in years zbecker Tue, 03/19/2024 - 11:19
Riding GLP-1 wave, Novo Nordisk lays out $560M to boost drug production in China esagonowsky Tue, 03/19/2024 - 11:07
In his final full year as AbbVie's CEO, Richard Gonzalez collects $25.7M in total pay kdunleavy Tue, 03/19/2024 - 10:31
IFF, after brief leadership stint under Merck's Frank Clyburn, pawns off pharma solutions business for $2.85B fkansteiner Tue, 03/19/2024 - 10:20
Regeneron advances antitrust lawsuit against Novartis with appeals court's backing aliu Tue, 03/19/2024 - 10:08
PTC, after multiple FDA rejections, will try again with Translarna esagonowsky Tue, 03/19/2024 - 09:44